http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-506865-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dd102b112504368b399732c4f5347ed
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
filingDate 2000-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0417a089ce8a5c6748096de88ef462f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2ea5560aedfe1958d11bcdf07983022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96de7ece3e756374c471875d225dae9a
publicationDate 2001-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-506865-A
titleOfInvention A drug delivery system formulation for fat soluble drugs such as vitamins A, D & K
abstract Described is an oral composition which may be formulated to self-emulsify under gentle agitation and in the presence of an aqueous medium. The composition comprises: (i) a fat-soluble drug selected from tocotrienols, tocopherols, and vitamins A, D, K and b-carotene; (ii) palm olein or soybean oil; and (iii) a surfactant system which is a combination of caprylocaproyl macrogolglycerides EP (Labrasol) and poloxyethylene 20 sorbitan monoleate (Tween 80).
priorityDate 2000-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61871
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517430
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ93MW7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426660723
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VG48
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497163
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U780
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UT41
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13798888
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55EU1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9L7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA8WGN9
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID8953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9929901
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26504
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495462
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19515
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID8953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408830802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412188633
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M1X5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280489
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5HKP6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4831

Total number of triples: 49.